Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines.

Cardiovasc Drugs Ther · 2022 · PMC9270274 · PMID 33689087

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

NSML mice treated with 0.05 mg/kg dasatinib showed a trend towards reduced HW/BW and HW/TL, while 0.1 mg/kg of dasatinib significantly reduced HW/BW and HW/TL as compared with vehicle-treated WT mice (Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.